L. Carrozzi (Pisa, Italy), C. Redlich (New Haven, Ct, United States of America)
Health care utilization of chronic obstructive pulmonary disease in Korea
H. H. Jeon, Y. S. Kim, S. K. Kim, Y. M. Oh, S. D. Lee (Seoul, Republic Of Korea)
|   |
Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids
V. Kiri, G. Visick, C. Chigbo, G. Hagan, H. Muellerova, K. Davis (Greenford, Middlesex, Cheshunt, Hertfordshire, United Kingdom; Research Triangle Park, NC, United States Of America)
| |
Advantages of FEV1/height2 and FEV1/height3 over percentage predicted value
S. Chinn, T. Gislason (London, United Kingdom; Reykjavik, Iceland)
| |
Incidence of community-acquired pneumonia episodes in COPD patients in England and Wales
H. Muellerova, V. Kiri, C. Chigbo, J. Wedzicha, M. Woodhead, M. Miravitlles, N. Boudiaf, G. Hagan, K. Davis (Greenford, Cheshunt, London, Manchester, United Kingdom; Barcelona, Spain)
| |
C-reactive protein in COPD and associations with smoking and body mass index
S. Frantz, U. Nihlen, G. Engstrom, C. G. Lofdahl, P. Wollmer (Malmo, Lund, Sweden)
| |
Measurement of COPD severity: further validation of a survey-based instrument
M. Eisner, P. Katz, C. Iribarren, E. Yelin, P. Blanc (San Francisco, CA, Oakland, CA, United States Of America)
| |
Urban air pollution and COPD emergency room visits
S. Cendon, M. Arbex, J. R. Batalha, F. F. Arbex, G. M. Conceição, A. C. Lopes, E. P. Moyses, S. L. Santiago, L. Pereira, A. L. F. Braga (Santos, São Paulo, Brazil)
| |
Inflammation-sensitive plasma proteins are associated with increased incidence of COPD
G. Engström, M. Ekberg-Aronsson, P. Nilsson, F. Lindgärde, C. G. Löfdahl (Malmö, Sweden)
| |
Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5
I. Romieu, R. Garcia-Esteban, J. Sunyer, C. Rios, F. Holguin (Cuernavaca, Morelos, Mexico, DF, Mexico; Barcelona, Spain; Atlanta, GA, United States Of America)
| |
Role of physical activity in clinical and functional status in COPD patients
J. Garcia-Aymerich, J. Roca, M. Orozco-Levi, A. Agustí, J. B. Gáldiz, J. Sauleda, R. Rodriguez-Roisin, J. M. Antó (Barcelona, Palma de Mallorca, Barakaldo, Spain)
| |
Neutrophilia is not associated with complications during hospitalisation
R. Schweizer, K. Velthove, M. Bracke, P. Souverein, M. Ten Berg, B. Leufkens, W. van Solinge (Utrecht, Netherlands)
| |
Measuring disease-specific utilities for chronic obstructive pulmonary disease (COPD) based on health profiles instead of health states
M. Rutten-van Molken, M. Hoogendoorn, L. Lamers (Rotterdam, Netherlands)
| |
Diagnosis and treatment of obstructive lung disease in Poland – results from the BOLD study in Poland
F. Mejza, J. Frey, E. Nizankowska-Mogilnicka, M. Twardowska, W. Skucha, R. Harat, A. Pajak, P. Nastalek, M. Allison, W. Volmer, S. Buist (Cracow, Chrzanow, Proszowice, Poland; Portland, OR, United States Of America)
| |
Health-related quality of life in women outpatients with COPD in daily practice
A. Martin, J. Rodriguez-GonzalezMoro, J. L. Izquierdo, E. Gobartt, I. Diaz, P. de Lucas (Madrid, Guadalajara, Barcelona, Spain)
| |
Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study
E. Balcells Vilarnau, J. Garcia-Aymerich, J. M. Antó (Barcelona, Spain)
| |
Tiotropium use in COPD: association with clinical diagnosis assignment
P. D. Blanc, M. D. Eisner, E. H. Yelin, G. Earnest, J. R. Balmes, P. P. Katz (San Francisco, CA, United States Of America)
| |
Mortality of patients with COPD
E. Shehu, J. Bushati (Tirana, Albania)
| |
Oxygen saturation in a COPD-cohort compared with age and sex matched controls
A. Lindberg, L. G. Larsson, A. C. Jonsson, S. Sundberg, L. Hedman, E. Rönmark, B. Lundbäck (Luleå, Umeå, Stockholm, Sweden)
| |
Asthma control and its determinants. The European community respiratory health survey (ECRHS) II
L. Cazzoletti, A. Marcon, C. Janson, S. Accordini, M. Bugiani, A. Gulsvik, D. Jarvis, R. de Marco (Verona, Italy)
| |